
Hyperglycemia in HR+ Breast Cancer: Prevention and Management Strategies for Oncology Pharmacists
Hormone receptor-positive (HR+) breast cancer (BC) is one of the most common BC subtypes, accounting for approximately 70% of all diagnoses. Of these cases, PIK3CA mutations occur in about 47% of patients. PIK3CA mutations carry various consequences for …